1959
Foundation of HAL Allergy (Haarlems Allergenen Laboratorium BV)
1966
Introduction of the first commercially available house-dust mite extract to combat house dust mite allergy
1986
Introduction of allergoid (glutaraldehyde modified) subcutaneous immunotherapy (SCIT) for grasses
1995
Introduction of SLIT product B.E.S.T. (buccal, enteral, sublingual) immunotherapy (SLIT)
1998
Introduction of SCIT bee and wasp venoms
2001
Introduction of allergoid (glutaraldehyde modified) subcutaneous immunotherapy (SCIT) for house dust mite allergy
2009
State-of-the-art facilities built at Leiden’s Bio Science Park, meeting Good Manufacturing Practice (GMP)
2016
Completion of first-in-human SCIT in peanut allergic patients
2018
First company to achieve marketing authorizations for SLIT birch and tree products from the German authorities according to Therapy Allergen Ordinance
2019
Completion of pivotal phase I study with SCIT peanut
2019
HAL Allergy’s anniversary: 60 years of research, development and production of causal treatments